Similarly, the 365-day mortality risk also showed an increasing trend (P for trend < 0.01), with both Q2 and Q3 groups significantly higher compared to Q1 (Q2: HR = 1.28, 95% CI 1.05–1.45; Q3: HR = 1.30, 95% CI 1.08–1.55).
← all excerpts
Triglyceride-glucose index and mortality in critically ill patients with cardiovascular-kidney-metabolic syndrome stage 4.
1
—
—